Studies on the neuroprotective effects of estrogen, i.e., beneficial effects against Parkinson disease and Alzheimer disease, suggest that estrogen-mediated neuroprotection is estrogen receptor (ER)-dependent at physiologic levels and ER-independent at pharmacological concentrations of the hormone [43]. Here, ESR1 is linked to Parkinson disease.